PCN11- ECONOMIC EVALUATION OF LIPOSOMAL DOXORUBICIN VS TOPOTECAN FOR RECURRENT OVARIAN CANCER IN THE UK
    
    
        Sep 1, 2001, 00:00
        
    
    
    
10.1046/j.1524-4733.2001.40202-57.x
https://www.valueinhealthjournal.com/article/S1098-3015(11)71216-5/fulltext
     Title :
    PCN11- ECONOMIC EVALUATION OF LIPOSOMAL DOXORUBICIN VS TOPOTECAN FOR RECURRENT OVARIAN CANCER IN THE UK    
     Citation :
    https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)71216-5&doi=10.1046/j.1524-4733.2001.40202-57.x    
     First page :
        
     Section Title :
        
     Open access? :
    
        No
     
     Section Order :
    108